The "Dual Chamber Injection Devices to 2024" report has been added to Research and Markets' offering. As biological drugs continue to grow in terms of therapeutics and total prescriptions, the impact ...
NEW YORK, Dec. 5, 2017 The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients has led to increasing ...
DUBLIN--(BUSINESS WIRE)--The "Dual Chamber Injection Devices to 2024" report has been added to Research and Markets' offering. As biological drugs continue to grow in terms of therapeutics and total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results